The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma

International Journal of Molecular Medicine

Volumn 23, Issue 1, 2009, Pages 121-129

  Pak, K C ^a   Lam, K Y ^b   Law, S ^c   Tang, Johnny Cheuk On ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti proliferation; Cyclooxygenase 2; Esophaegal squamous cell carcinoma; Gene over expression

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLEDITSIA SINENSIS EXTRACT; MESSENGER RNA; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CYTOTOXIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; ENZYME SPECIFICITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; GLEDITSIA; GLEDITSIA SINENSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL PROLIFERATION; CHEMISTRY; ENZYMOLOGY; ESOPHAGUS TUMOR; FRUIT; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; PHYTOTHERAPY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; CYTOTOXINS; ESOPHAGEAL NEOPLASMS; FRUIT; GENE EXPRESSION REGULATION; GLEDITSIA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 61749090021     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000109     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlya J and Pisani P: Global cancer statistics. CA Cancer J Clin 55: 74-108, 2005.
2. Lam AKY: Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33: 71-90, 2000.
3. Law S and Wong J: Changing disease burdens and management issues for esophageal cancers in the Asia-Pacific region. J Gastroenterol Hepatol 17: 374-381, 2002.
4. Chandrasekharan NV and Simmons DL: The cyclooxygenases. Genome Biol 5: 241, 2004.
5. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Putte LBAVD and Lipsky PE: Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
6. Tanabe T and Tohnai N: Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 68-69: 95-114, 2002.
7. Hinz B and Brune K: Cyclooxygenase-2 10 years later. J Pharmacol Exp Ther 300: 367-375, 2001.
8. Zimmermann KC, Sarbia MA, Weber AA, Borchard F, Gabbert HE and Schror K: Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59: 198-204, 1999.
9. Liu CH, Chang Sh, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF and Hla T: Overexpression of cyclooxygenase 2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276: 18563-18569, 2001.
10. Zhi H, Wang L, Zhang J, Zhou C, Ding F, Luo A, Wu M, Zhan Q and Liu Z: Significance of COX-2 expression in human esophageal squamous cell carcinoma. Carcinogenesis 27: 1214-1221, 2006.
11. Kase S, Osaki M, Honjo S, Adachi H, Tsujitani S, Kaibara N and Ito H: Expression of cyclooxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squmaous cell carcinomas. Virchows Arch 442: 129-135, 2003.
12. Leahy KM, Koki AT and Masferrer JL: Role of cyclooxygenases in angiogenesis. Curr Med Chem 7: 1163-1170, 2000.
13. Mazhar D, Gillmore R and Waxman J: COX and cancer. Q J Med 98: 711-718, 2005.
14. Wang W, Bergh A and Damber JE: Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 11: 3250-3256, 2005.
15. Williams CS, Mann M and DuBois RN: The role of cyclooxygenase-2 in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999.
16. Subbaramaiah K and Dannenberg AJ: Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24: 96-102, 2003.
17. Xu XC: COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13: 127-137, 2002.
18. Altork N: COX-2: A target for prevention and treatment of esophageal cancer. J Surg Res 117: 114-120, 2004.
19. Schreinemachers DM and Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138, 1994.
20. Hawkey CJ and Langman MJS: Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary role for COX-2 inhibitors and proton pump inhibitors. Gut 52: 600-608, 2003.
21. Andersohn F, Suissa S and Garbe E: Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 113: 1950-1957, 2006.
22. Chow LCM, Tang JCO, Teo ITN, Chui CH, Lau FY, Leung TWT, Cheng G, Wong RSM, Wong ILK, Tsang KMS, Tan WQ, Zhao YZ, Lai KB, Lam WH, Guo DA and Chan ASC: Antiproliferative activity of the extract of Gleditsia sinensis fruit on human solid tumour cell lines. Chemotherapy 48: 303-308, 2002.
23. Zhang Z, Koike K, Jia Z, Nikaido T, Guo D and Zheng J: Triter-penoidal saponins from Gleditsia sinensis. Phytochemistry 52: 715-722, 1999.
24. Kim JC, Park JH, Budesinsky M, Kasal A, Han YH, Koo BS, Lee SI and Lee DU: Antimutagenic constituents from the thorns of Gleditsia sinensis. Chem Pharm Bull 53: 561-564, 2005.
25. Zhong L, Li P, Ha J, Qu G and Guo D: Structure-activity relationships of saponins from Gleditsia sinensis in cytotoxicity and induction of apoptosis. Planta Med 70: 797-802, 2004.
26. Chow LMC, Chui CH, Tang JCO, Teo ITN, Lau FY, Cheng GYM, Wong RSM, Leung TWT, Lai KB, Yau MYC, Guo D and Chan ASC: Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia. Oncol Rep 10: 1601-1607, 2003.
27. Chui CH, Tang JCO, Lau FY, Teo ITN, Yau MYC, Wong RSM, Cheng GYM, Ho SKW, Leung TWT, Hui KS and Wong MM: Gleditsia sinensis fruit extract-induced growth inhibition involves basic fibroblast growth factor and nitric oxide. Int J Mol Med 13: 169-173, 2004.
28. Chow LMC, Chui CH, Tang JCO, Lau FY, Yau MYC, Cheng GYM, Wong RSM, Lai PBS, Leung TWT, Teo ITN, Cheung F, Guo D and Chan ASC: Anti-angiogenic potential of Gleditsia sinensis fruit extract. Int J Mol Med 12: 269-273, 2003.
29. Chui CH, Lau DFY, Chan ASC, Cheng GYM, Wong RSM, Lai KB, Kok SHL, Au Yeung TTL, Teo ITN, Yau MYC, Cheung F, Cheng CH and Tang JCO: Gleditsia sinensis fruit extract-induced apoptosis involves changes of reactive oxygen species level, mitochondrial membrane depolarization and caspase 3 activation. Int J Mol Med 15: 539-543, 2005.
30. Cheung F, Chui CH, Chan ASC, Lau FY, Cheng GYM, Wong RSM, Kok SHL, Teo ITN, Cheng CH and Tang JCO: Inhibition of proteasome activity in Gleditsia sinensis fruit extract-mediated apoptosis on human carcinoma cells. Int J Mol Med 16: 925-929, 2005.
31. Teo ITN, Tang JCO, Chui CH, Cheng GYM, Yau MYC, Lau FY, Wong RSM, Leung TWT, Cheung F, Ho KP, Cheng CH and Chan ASC: Superoxide anion is involved in the early apoptosis mediated by Gleditsia sinensis fruit extract. Int J Mol Med 13: 909-913, 2004.
32. Tang WK, Chui CH, Fatima S, Kok SHK, Pak KC, Ou TM, Hui KS, Wong MM, Wong J, Law S, Tsao SW, Lam KY, Beh PSL, Srivastava G, Ho KP, Chan ASC and Tang JCO: Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma. Int J Mol Med 19: 953-960, 2007.
33. Hu YC, Lam KY, Law SY, Wan TSK, Ma ESK, Kwong YL, Chan LC, Wong J and Srivastava G: Establishment, characterization, karyotyping, and comparative genome hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 135: 120-127, 2002.
34. Cheung LCM, Tang JCO, Lee PY, Hu L, Guan XY, Tang WK, Srivastava G, Wong J, Luk JM and Law S: Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line HKESC-4 of Chinese origin. Cancer Genet Cytogenet 178: 17-25, 2007.
35. Tang JCO, Wan TSK, Wong N, Pang E, Lam KY, Law SY, Chow LMC, Ma ESK, Chan LC, Wong J and Srivastava G: Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genet Cytogenet 124: 36-41, 2001.
36. Shimada Y, Imamura M, Wagata T, Yamaguchi N and Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284, 1992.
37. Fatima S, Chui CH, Tang WK, Hui KS, Au HW, Li WY, Wong MM, Cheung F, Tsao SW, Lam KY, Beh PSL, Wong J, Law S, Srivastava G, Ho KP, Chan ASC and Tang JCO: Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma. Int J Mol Med 17: 159-170, 2006.
38. Zhang H, Jin YS, Chen XH, Jin C, Law S, Tsao SW and Kwong YL: Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet 165: 25-35, 2006.
39. Hussain T, Gupta S, Adhami VM and Mukhtar H: Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 113: 660-669, 2005.
40. Kang K, Kubin M, Cooper KD, Lessin KD, Trinchieri G and Rook AH: IL-12 synthesis by human langerhan cells. J Immunol 156: 1402-1407, 1996.
41. Miyazono F, Metzger R, Warnecke-Eberz U, Baldus SE, Brabender J, Bollschweiler E, Doerfler W, Mueller RP, Dienes HP, Aikou T, Hoelscher AH and Schneider PM: Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesphageal cancer. Br J Cancer 91: 666-672, 2004.
42. Zhou C, Liu S, Zhou X, Xue L, Quan L, Lu N, Zhang G, Bai J, Wang Y, Liu Z, Zhan Q, Zhu H and Xu N: Over-expression of human pituitary tumor transforming gene (hPTTG) is regulated by β-catenin/TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 113: 891-898, 2005.
43. Lau FY, Chui CH, Gambari R, Kok SHL, Kan KL, Cheng GYM, Wong RSM, Teo ITN, Cheng CH, Wan TSK, Chan ASC and Tang JCO: Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells. Int J Mol Med 16: 1157-1162, 2005.
44. Shoemaker M, Hamilton B, Dairkee SH, Cohen I and Campbell MJ: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 19: 649-651, 2005.
45. Klein R, Brown D and Turnle AM: Phenoxodiol protects against Cisplatin-induced neurite toxicity in a PC-12 cell model. BMC Neurosci 8: 61, 2007.
46. Schwartz MA: Integrins, oncogenes, and anchorage independence. J Cell Biol 139: 575-578, 1997.